Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GVAX in Metastatic Hormone-Refractory Prostate Cancer
NCT00140348Phase 2Completed
- Sponsor
- Cell Genesys
- Start
- Dec 2001
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GVAX pancreatic cancer vaccine in prostate cancer (PCa), sponsored by Cell Genesys. Started Dec 2001; status: completed.
02
Drugs
GVAX pancreatic cancer vaccine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00140348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140348.